Cytopathogenic Effect, Viral
"Cytopathogenic Effect, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses.
| Descriptor ID |
D003588
|
| MeSH Number(s) |
E01.370.225.500.384.235 E05.200.500.384.235 E05.242.384.235 G06.920.190
|
| Concept/Terms |
Cytopathogenic Effect, Viral- Cytopathogenic Effect, Viral
- Cytopathic Effect, Viral
- Cytopathic Effects, Viral
- Effect, Viral Cytopathic
- Effects, Viral Cytopathic
- Viral Cytopathic Effect
- Viral Cytopathic Effects
- Viral Cytopathogenic Effect
- Cytopathogenic Effects, Viral
- Effect, Viral Cytopathogenic
- Effects, Viral Cytopathogenic
- Viral Cytopathogenic Effects
|
Below are MeSH descriptors whose meaning is more general than "Cytopathogenic Effect, Viral".
Below are MeSH descriptors whose meaning is more specific than "Cytopathogenic Effect, Viral".
This graph shows the total number of publications written about "Cytopathogenic Effect, Viral" by people in this website by year, and whether "Cytopathogenic Effect, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cytopathogenic Effect, Viral" by people in Profiles.
-
Wu C, Nerurkar VR, Yanagihara R, Lu Y. Effective modifications for improved homologous recombination and high-efficiency generation of recombinant adenovirus-based vectors. J Virol Methods. 2008 Nov; 153(2):120-8.
-
Verma S, Molina Y, Lo YY, Cropp B, Nakano C, Yanagihara R, Nerurkar VR. In vitro effects of selenium deficiency on West Nile virus replication and cytopathogenicity. Virol J. 2008 May 31; 5:66.
-
Lu Y, Aguirre AA, Wang Y, Zeng L, Loh PC, Yanagihara R. Viral susceptibility of newly established cell lines from the Hawaiian monk seal Monachus schauinslandi. Dis Aquat Organ. 2003 Dec 29; 57(3):183-91.
-
Kong W, Tian C, Liu B, Yu XF. Stable expression of primary human immunodeficiency virus type 1 structural gene products by use of a noncytopathic sindbis virus vector. J Virol. 2002 Nov; 76(22):11434-9.
-
George J, Raju R. Alphavirus RNA genome repair and evolution: molecular characterization of infectious sindbis virus isolates lacking a known conserved motif at the 3' end of the genome. J Virol. 2000 Oct; 74(20):9776-85.
-
Boehme KW, Williams JC, Johnston RE, Heidner HW. Linkage of an alphavirus host-range restriction to the carbohydrate-processing phenotypes of the host cell. J Gen Virol. 2000 Jan; 81(Pt 1):161-70.
-
Choi B, Gatti PJ, Haislip AM, Fermin CD, Garry RF. Role of potassium in human immunodeficiency virus production and cytopathic effects. Virology. 1998 Aug 01; 247(2):189-99.
-
Garry RF, Fermin CD, Kohler PF, Markert ML, Luo H. Antibodies against retroviral proteins and nuclear antigens in a subset of idiopathic CD4+ T lymphocytopenia patients. AIDS Res Hum Retroviruses. 1996 Jul 01; 12(10):931-40.
-
Voss TG, Gatti PJ, Fermin CD, Garry RF. Reduction of human immunodeficiency virus production and cytopathic effects by inhibitors of the Na+/K+/2Cl- cotransporter. Virology. 1996 May 01; 219(1):291-4.
-
Yanagihara R, Silverman DJ. Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Arch Virol. 1990; 111(3-4):281-6.